MedicalResearch.com Interview with:
[caption id="attachment_61322" align="alignleft" width="150"]
Dr. Ooi[/caption]
A/Prof. Joshua Ooi, PhD
Head, Regulatory T-cell Therapies
Translational Research Facility
Clinical Sciences at Monash Health,
Monash University
MedicalResearch.com: What is the background for this study?
Response: In 2017, we published a landmark Nature paper showing that people who are protected from autoimmune disease have specialized molecules on immune cells. These specific molecules are missing in patients that develop autoimmune disease.
